Zobrazeno 1 - 10
of 10
pro vyhledávání: '"398"'
Autor:
N. Oda, M. Sakuragi, K. Ito, A. Miura, T. Utsugi, H. Hirai, Y. Nakatsuru, H. Sootome, A. Hashimoto
Publikováno v:
European Journal of Cancer. 50:127-128
Publikováno v:
European Journal of Cancer. 48:S158-S159
Autor:
Gulcin Tezcan, Sahsine Tolunay, Unal Egeli, Gulsah Cecener, Ismet Tasdelen, S. Gokgoz, E. Erturk, Berrin Tunca
Publikováno v:
European Journal of Cancer. 50:S95
Autor:
Sandrine Faivre, M.E. Riveiro, A. de Gramont, A. Raballand, P. Ruszniewski, Pascal Hammel, Eric Raymond, L. Astorgues-Xerri, M. Serova, Cindy Neuzillet
Publikováno v:
European Journal of Cancer. 48:121
Autor:
G. Cantu, G. Bonadonna, Gianni Ravasi, P. Bidoli, Roberto Zucali, Antonella Santoro, M. Valente, H. Soto Parra
Publikováno v:
European Journal of Cancer. 31:S87
In order to evaluate a new strategy to increase long term survival avoiding laryngoesophagectomy (LE), from 5/1985 to 12/1993, 37 pts with CSCCE were treated with combined CT (CDDP 100 mg/sqm, day 1, FU 1000mg/m2 q, day 1–4 in 96 h infusion) every
Autor:
Rachel Wuerstlein, Margarita Donica, Antonio Anton, Jacques Bonneterre, Suzette Delaloge, N Quenel-Tueux, Natsumi Irahara, Nicolas Lindegger, Sabine C. Linn, Carlos H. Barrios, Paul Anthony Ellis, Filippo Montemurro
Publikováno v:
European Journal of Cancer. 109:92-102
Background Many patients with metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) are candidates for trastuzumab emtansine (T-DM1) treatment sometime in their disease history. KAMILLA evaluated safety of T-DM1 in pa
Autor:
A. Briffaux, J.F. Bosset, L. Radosevic-Jelic, Gilles Calais, Alain Daban, Etienne Bardet, Marianne Pierart, P. Maingon, C. Berger
Publikováno v:
European Journal of Cancer. 40:219-224
The European Organisation for Research and Treatment of Cancer (EORTC) 22921 four-arm randomised trial questioned the value of preoperative chemoradiation (XRT-CT) versus preoperative radiation (XRT) and the value of additional postoperative chemothe
Publikováno v:
European Journal of Cancer. 32:480-490
The Ann Arbor staging classification has long been recognised to have shortcomings when used to stage the follicular lymphomas. To date, the identification of important prognostic variables has not succeeded in producing a superior staging classifica
Publikováno v:
European Journal of Cancer. 31:S234
The amino acid, l-glutamine is the major energy substrate of the intestinal epithelium. Dietary supplementation reduces GI toxicity after RT and CT in animal models. The maximal insult to the gut occurs during high dose conditioning therapy and in th
Publikováno v:
European Journal of Cancer. 31:S254
This 24-hour trial randomized 398 cancer patients at 26 centers to 25, 50, 100, 200 mg DM or OND (8 mg × 4; 8 mg × 3 at four centers) prior to IV CT primarily with cyclophosphamide (≥ 600 mg/m2), doxorubicin (≥ 40 mg/m2), or carboplatin (≥ 30